Open access
Open access
Powered by Google Translator Translator

Infectious Diseases (all articles)

Editorial | Covid-19: variants and vaccination

24 Mar, 2021 | 08:32h | UTC

Covid-19: variants and vaccination – The BMJ

 

World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis

24 Mar, 2021 | 08:19h | UTC

COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis, Global Investment Needed – Health Policy Watch

Report: One year on, new data show global impact of covid-19 on TB epidemic is worse than expected – Stop TB Partnership

See also: 1.4 million with tuberculosis, lost out on treatment during first year of COVID-19 – United Nations

 

Perspective | Don’t Be Surprised When Vaccinated People Get Infected

24 Mar, 2021 | 08:28h | UTC

Don’t Be Surprised When Vaccinated People Get Infected – The Atlantic

 

Opinion | Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks

24 Mar, 2021 | 08:22h | UTC

Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks – The Lancet Microbe

 

Commentary on Twitter

 

Study: More than half of antibiotics prescribed in US hospitals were not consistent with recommended prescribing practices

21 Mar, 2021 | 21:44h | UTC

Assessment of the Appropriateness of Antimicrobial Use in US Hospitals

Commentary: New findings spur call to reduce improper antibiotic use in hospitals – CIDRAP

 

Commentary on Twitter

 

Systematic review: Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease

23 Mar, 2021 | 02:09h | UTC

Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease – Cochrane Library

 

M-A: Most patients with allergy to Penicillin can be given Cefazolin

21 Mar, 2021 | 21:41h | UTC

Assessment of the Frequency of Dual Allergy to Penicillins and Cefazolin: A Systematic Review and Meta-analysis – JAMA Surgery

Commentary: Common antibiotic can safely be given to most surgery patients despite penicillin allergy – Massachusetts General Hospital

 

Commentary on Twitter (thread – click for more)

 

Cohort study: Non-communicable disease, sociodemographic factors, and risk of death from infection

23 Mar, 2021 | 02:05h | UTC

Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study – The Lancet Infectious Diseases

 

Commentary on Twitter (thread – Click for more)

 

[Press release – not published yet] AstraZeneca vaccine 79% effective for preventing symptomatic COVID-19

23 Mar, 2021 | 02:36h | UTC

AZD1222 US Phase III trial met primary efficacy endpoint in preventing COVID-19 at interim analysis – AstraZeneca

Commentaries: AstraZeneca vaccine is 79% effective against symptomatic Covid-19, company says – CNN AND AstraZeneca’s Covid-19 vaccine shows better-than-expected efficacy in U.S. trial – STAT AND Expert reaction to press release from AstraZeneca announcing interim data on safety and efficacy from the US trial of the Oxford-AstraZeneca COVID-19 vaccine – Science Media Centre AND AstraZeneca Publishes Reassuring Trial Data, But Vaccine Hesitancy Remains Widespread In European Union – Health Policy Watch

 

Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery

23 Mar, 2021 | 02:33h | UTC

SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery – Anaesthesia

Related: Study from 116 countries suggests surgery should be delayed for at least seven weeks following a COVID-19 diagnosis to reduce mortality risk – Anaesthesia

 

Commentary on Twitter

 

EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomized clinical trials

23 Mar, 2021 | 02:30h | UTC

EMA advises against use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials – European Medicines Agency

Related: FDA: Why you should not use Ivermectin to treat or prevent COVID-19 (statement, commentary, and RCT)

 

Opinion | We need to start thinking more critically — and speaking more cautiously — about long Covid

23 Mar, 2021 | 02:28h | UTC

We need to start thinking more critically — and speaking more cautiously — about long Covid – STAT

 

Review | Post-acute COVID-19 syndrome

23 Mar, 2021 | 02:26h | UTC

Post-acute COVID-19 syndrome – Nature Medicine

News Release: Study underscores need for multidisciplinary care for COVID-19 long-haulers – Dana-Farber Cancer Institute

 

Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study

23 Mar, 2021 | 02:20h | UTC

Lung ultrasound for the early diagnosis of COVID-19 pneumonia: an international multicenter study – Intensive Care Medicine

 

Commentary on Twitter

 

Editorial | Scholarly communications harmed by covid-19

23 Mar, 2021 | 02:25h | UTC

Scholarly communications harmed by covid-19 – The BMJ

 

Commentaries on Twitter

 

Covid-19 disruptions killed 228,000 children in South Asia, says UN report

23 Mar, 2021 | 02:22h | UTC

Covid-19 disruptions killed 228,000 children in South Asia, says UN report – BBC

Report: Direct and indirect effects of the COVID-19 pandemic and response in South Asia – United Nations

 

Opinion | An open plea for dignity and respect in science

23 Mar, 2021 | 02:24h | UTC

An open plea for dignity and respect in science – The BMJ Opinion

Related: Scientists who express different views on Covid-19 should be heard, not demonized – STAT

 

Commentary on Twitter

 

Expert consensus statements for the management of COVID-19-related acute respiratory failure

21 Mar, 2021 | 22:05h | UTC

Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method – Critical Care

 

Commentary on Twitter

 

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

21 Mar, 2021 | 21:34h | UTC

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition – New England Journal of Medicine (link to abstract – $ for full-text)

 

Infection and mRNA vaccine-induced immunity may be retained against SARS-CoV-2 variant B.1.1.7

21 Mar, 2021 | 22:04h | UTC

Neutralizing Antibodies Against SARS-CoV-2 Variants After Infection and Vaccination – JAMA

 

SARS-CoV-2 variants B.1.351 and P.1 can escape from therapeutic antibodies and evade antibodies induced by infection or mRNA vaccination

21 Mar, 2021 | 22:02h | UTC

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies – Cell

 

CDC Guidance for schools says students can now stay 3 feet apart, rather than 6

21 Mar, 2021 | 22:07h | UTC

CDC Guidance: CDC Updates Operational Strategy for K-12 Schools to Reflect New Evidence on Physical Distance in Classrooms – Centers for Disease Control and Prevention

See also: Operational Strategy for K-12 Schools through Phased Prevention – Centers for Disease Control and Prevention

Commentaries: CDC Says Schools Can Now Space Students 3 Feet Apart, Rather Than 6 – NPR AND CDC updates COVID school guidance, OKs 3-feet distancing – CIDRAP

Related: Cohort study: Effectiveness of three vs. six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff (study and commentary)

 

Commentaries on Twitter

 

[Preprint] Oxford/AstraZeneca and Pfizer/BioNTech vaccines probably can still neutralize P.1 strain of SARS-CoV-2, but at lower levels

21 Mar, 2021 | 21:55h | UTC

Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2 – bioRxiv

Commentary: Existing COVID vaccines may protect against Brazilian variant – Oxford study – Reuters

 

B.1.351 strain of SARS-CoV-2 neutralization titer reduced 8- to 9-fold for Pfizer and AstraZeneca vaccinees. Convalescent plasma and therapeutic antibodies were less effective against this variant as well.

21 Mar, 2021 | 21:52h | UTC

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera – Cell

 

Bioethics | “Europe’s Vaccine Ethics Call: Do No Harm and Let More Die?”

21 Mar, 2021 | 21:50h | UTC

Europe’s Vaccine Ethics Call: Do No Harm and Let More Die? – The New York Times (free registration may be required)

Related opinion: Covid-19 vaccine adverse events: balancing monitoring with confidence in vaccines – The BMJ Opinion

See also: European Medicines Agency finds AstraZeneca vaccine is safe and benefits outweigh the risks (Statement and commentaries) AND Statement of the WHO Global Advisory Committee on Vaccine Safety (GACVS) COVID-19 subcommittee on safety signals related to the AstraZeneca COVID-19 vaccine – World Health Organization AND Update on the safety of COVID-19 Vaccine AstraZeneca (statement and commentaries)

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.